Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetic Impact on CellCept Use in Renal Transplant Recipients
2016-001042-25Phase 4
- Sponsor
- Roche
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate mofetil in Kidney allograft status (RTx), kidney transplant, kidney allograft rejection, sponsored by Roche.
02
Drugs
mycophenolate mofetil
03
Conditions
Kidney allograft status (RTx)kidney transplantkidney allograft rejection
Beyond the preview
Go deeper on 2016-001042-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001042-25.